Compounds > morpholinoanthracycline mx2

Page last updated: 2024-09-02

morpholinoanthracycline mx2 and Neutropenia

morpholinoanthracycline mx2 has been researched along with Neutropenia in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	4 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fukue, H; Fukutake, K; Gohchi, K; Ishigatsubo, Y; Kimura, S; Koitabashi, Y; Matsuda, J; Okubo, T; Shimada, K; Yamada, K	1
Basser, RL; Cebon, J; Clarke, K; Geldard, H; Green, MD; Hill, JS; Kaye, AH; Maher, DW; Morgan, DJ; Park, SJ; Stylli, SS	1
Alt, C; Bartlett, J; Basser, RL; Cebon, J; Clarke, K; Fox, RM; Geldard, H; Green, MD; Hill, JS; Kaye, AH; Maher, D; Morgan, DJ	1
Bartlett, J; Basser, RL; Byrne, M; Cher, L; Clarke, K; Dalley, D; Findlay, M; Fox, RM; Geldard, H; Green, MD; Hill, JS; Kaye, AH; Maher, D; Mitchell, P; Pell, M; Underhill, C	1

Trials

4 trial(s) available for morpholinoanthracycline mx2 and Neutropenia

Article	Year
[Phase III clinical trial of KRN8601 (rhG-CSF) for neutropenia in patients with human immunodeficiency virus infection]. Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 1994, Volume: 68, Issue:9 Topics: Adolescent; Adult; Carubicin; Female; HIV Infections; Humans; Infusions, Intravenous; Male; Middle Aged; Neutropenia	1994
Pharmacokinetics and pharmacodynamics of MX2 hydrochloride in patients with advanced malignant disease. Cancer chemotherapy and pharmacology, 1997, Volume: 40, Issue:3 Topics: Adult; Aged; Antibiotics, Antineoplastic; Area Under Curve; Carubicin; Doxorubicin; Female; Half-Life; Humans; Injections, Intravenous; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Neutropenia; Neutrophils; Safety	1997
Phase I and pharmacokinetic study of KRN8602 alone and with filgrastim in patients with advanced cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:6 Topics: Adult; Aged; Antibiotics, Antineoplastic; Carubicin; Dose-Response Relationship, Drug; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Recombinant Proteins; Treatment Outcome	1998
KRN8602 (MX2-hydrochloride): an active new agent for the treatment of recurrent high-grade glioma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1999, Volume: 17, Issue:8 Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Astrocytoma; Brain Neoplasms; Carubicin; Combined Modality Therapy; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Survival Analysis	1999